APA

Özkan A., Uçar B., Seymen H., Yildiz Yarar Y., Falay F. O. & Demirkol M. O. (20200706). Posttherapeutic Critical Organ Dosimetry of Extensive 177Lu-PSMA Inhibitor Therapy With Metastatic Castration-Resistant Prostate Cancer: One Center Results. : Clinical nuclear medicine.

Chicago

Özkan Ahu, Uçar Burcu, Seymen Hülya, Yildiz Yarar Yasemin, Falay Fikri Okan and Demirkol Mehmet Onur. 20200706. Posttherapeutic Critical Organ Dosimetry of Extensive 177Lu-PSMA Inhibitor Therapy With Metastatic Castration-Resistant Prostate Cancer: One Center Results. : Clinical nuclear medicine.

Harvard

Özkan A., Uçar B., Seymen H., Yildiz Yarar Y., Falay F. O. and Demirkol M. O. (20200706). Posttherapeutic Critical Organ Dosimetry of Extensive 177Lu-PSMA Inhibitor Therapy With Metastatic Castration-Resistant Prostate Cancer: One Center Results. : Clinical nuclear medicine.

MLA

Özkan Ahu, Uçar Burcu, Seymen Hülya, Yildiz Yarar Yasemin, Falay Fikri Okan and Demirkol Mehmet Onur. Posttherapeutic Critical Organ Dosimetry of Extensive 177Lu-PSMA Inhibitor Therapy With Metastatic Castration-Resistant Prostate Cancer: One Center Results. : Clinical nuclear medicine. 20200706.